Sort
17,288 grants matching “multiple sclerosis”
MECHANISMS GOVERNING THE VIABILITY OF AXONS AND NEURONS IN THE EAE MOUSE MODEL OF MULTIPLE SCLEROSIS
$930,000Regents Of The University Of Minnesota · · FY2022 · Defense Health Agency
Mechanisms of sphingolipid signaling in vascular health and disease
$926,656Timothy Tun Hla · Boston Children'S Hospital · R35 · FY2017 · HL
TISSUE INJURY AND INFLAMMATION IN MULTIPLE SCLEROSIS
$925,059Cleveland Clinic Foundation · P01 · FY2002 · NS
Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder
$924,935Parag Gad · Spinex, Inc. · R44 · FY2022 · DK
Decoding and targeting the PI3K-mTOR signaling network in cancer
$924,904Brendan D. Manning · Harvard School Of Public Health · R35 · FY2016 · CA
Decoding and targeting the PI3K-mTOR signaling network in cancer
$924,904Brendan D. Manning · Harvard School Of Public Health · R35 · FY2018 · CA
Decoding and targeting the PI3K-mTOR signaling network in cancer
$924,904Brendan D. Manning · Harvard School Of Public Health · R35 · FY2017 · CA
Cancer Deep Phenotype Extraction from Electronic Medical Records
$924,689Guergana K. Savova · Boston Children'S Hospital · U24 · FY2020 · CA
TDP-43 aggregation inhibitors for the treatment of ALS
$923,960Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2018 · NS
A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis
$922,693Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · AI
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
$922,109Rhonda R Voskuhl · University Of California Los Angeles · R35 · FY2025 · NS
Novel Interactions Between the Immune and Neuroendocrine Systems
$922,001Dennis D. Taub · National Institute On Aging · ZIA · FY2012 · AG
Neurovascualar Regeneration
$921,756Karen K Hirschi · Yale University · R01 · FY2017 · EB
CENTER FOR COMPUTATIONAL BIOLOGY: BIOLOGICAL PROJECTS
$921,122Arthur W Toga · University Of California Los Angeles · U54 · FY2008 · RR
Genetics, Natural History, and Pathophysiology of Behcet's Disease
$920,836Daniel Kastner · National Human Genome Research Institute · ZIA · FY2011 · HG
Translational studies of human viruses and chronic neurologic disease
$918,380Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Brain-enriched microRNAs detectable in plasma as biomarkers of Alzheimer's disease
$916,749Samuil R Umansky · Diamir, Llc · R44 · FY2017 · AG
EMERGE PHASE III CLINICAL CENTER AT PARTNERS HEALTHCARE
$916,160Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2017 · HG
Role of Microglia Somatic Variants in Neurodegenerative Diseases
$915,897Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2023 · NS
Measuring cellular senescence to predict and prevent peripheral neuropathy
$914,673Natalia Mitin · Sapere Bio, Inc. · R44 · FY2021 · AG
Modeling Alzheimer's Disease Related Dementias in the Marmoset
$914,661Kuo-Fen Lee · Salk Institute For Biological Studies · R33 · FY2023 · NS
PENN AUTOIMMUNITY CENTER OF EXCELLENCE
$914,654University Of Pennsylvania · U19 · FY2002 · AI
Safe and effective anti CD154 antibodies for therapeutic intervention
$912,191Jay L Rothstein · Immunext, Inc. · R44 · FY2017 · AI
Safe and effective anti CD154 antibodies for therapeutic intervention
$912,191Jay L Rothstein · Immunext, Inc. · R44 · FY2016 · AI
Targeted depletion of programmed death-1 positive cells, a method that not only stops autoimmune attack but also preserves adaptive immunity
$912,099Mingnan Chen · University Of Utah · R01 · FY2024 · AI